APA (7th ed.) Citation

Heger, U., Martens, A., Schillings, L., Walter, B., Hartmann, D., Hinz, U., . . . Hackert, T. (2022). Myofibroblastic CAF density, not activated stroma index, indicates prognosis after neoadjuvant therapy of pancreatic carcinoma. Cancers, 14(16), . https://doi.org/10.3390/cancers14163881

Chicago Style (17th ed.) Citation

Heger, Ulrike, et al. "Myofibroblastic CAF Density, Not Activated Stroma Index, Indicates Prognosis After Neoadjuvant Therapy of Pancreatic Carcinoma." Cancers 14, no. 16 (2022). https://doi.org/10.3390/cancers14163881.

MLA (9th ed.) Citation

Heger, Ulrike, et al. "Myofibroblastic CAF Density, Not Activated Stroma Index, Indicates Prognosis After Neoadjuvant Therapy of Pancreatic Carcinoma." Cancers, vol. 14, no. 16, 2022, https://doi.org/10.3390/cancers14163881.